BioCryst Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6-$11.22 |
Market Cap | $2.5B |
Shares Short | 32M |
Financials
See moreRevenue (12 Mos) | $940.6M |
Revenue Growth (YoY) | 33.6% |
Gross Profit (12 Mos) | $727.9M |
Diluted EPS | -$1.40 |
News
See moreYahoo Finance • 17 days ago
BioCryst (BCRX) Q2 2026 Earnings Call Transcript
Yahoo Finance • 18 days ago
A Profitable Rare-Disease Prize: Who Might Snap Up BioCryst?
Yahoo Finance • 24 days ago
BioCryst Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
Yahoo Finance • 24 days ago
Biocryst outlines $690M-$715M 2026 total revenue guidance with operating costs at $420M-$440M
About
CEO | Mr. Charles K. Gayer |
CFO | Mr. Babar Ghias |
Address | 4505 Emperor Boulevard, Durham, NC, United States, 27703 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 435 |